Therefore, the goal of our study was to assess the usefulness of serum ADAM15 as a potential novel tumor marker of CRC in comparison to well-established tumor markers such as CEA and CA 19-9, as well as CRP. This evidence concerns the gene CEACAM5 and colorectal carcinoma.